Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs071180060Completed
Randomised trial of mizoribine in nephrosis (2 arms), sponsored by Ministry of Health, Labour and Welfare Scientific Research Grant. Primary endpoint: Duration from registration to diagnosis of frequently relapsing nephrotic syndrome. Started Jun 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs071180060.